Summary
68 / 100 · Bulios Score
What speaks for it
- Revenue grew by 7.3% a year over the last 3 years.
- Analysts expect revenue to grow by 22% this fiscal year.
- Out of every 100 JPY of revenue, 8.9 JPY is left as free cash.
What to watch
- The share price is above the Bulios Fair Price.
- Earnings per share fell by 11% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 15.2 JPY for 1 JPY of yearly profit. Over the last five years it was 23.0 JPY on average.
Valuation in detailIs it growing?
SlowlyRevenue (JPY)
Diluted EPS (JPY)
- Analyst estimate
Revenue grew by 9.2% a year over 5 years. Over the last 3 years it grew by 7.3% a year. For the next fiscal year analysts expect revenue to grow by 22%. Earnings per share fell by 11% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 JPY of revenue goes
- Cost of sales 76 JPY
- Sales and administration 12 JPY
- Taxes and other 3.2 JPY
- Net profit 8.4 JPY
Net profit, industry median (Chemicals - Specialty) 6.0 JPY
Out of every 100 JPY of revenue, 8.4 JPY is left as net profit.
Profitability in detailIs it financially healthy?
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 0.97%
- Paid out of profit
- 15%
You receive $0.32 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.